4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

11.99

+0.34 (2.92%)

Aug 14, 2026, 3:44 PM EDT - Market open

4D Molecular Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	92.01	85.21	0.04	20.72	3.13	18.04
Revenue Growth	278712.12%	230194.59%	-99.82%	562.29%	-82.65%	32.52%
Gross Profit	-100.49	-107.29	-141.26	-76.37	-77.12	-43.32
Operating Income	-193.92	-156.35	-187.84	-112.87	-110.03	-71.33
Net Income	-179.18	-140.11	-160.87	-100.84	-107.49	-71.32
Earnings Per Share	-2.77	-2.42	-2.98	-2.58	-3.32	-2.57
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Japan	85	-	-	-	-
United States	0.21	0.04	20.16	0.04	0.12
Total	85.21	0.04	20.72	3.13	18.04

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	430.63	514.03	505.46	299.19	218.46	315.43
Total Debt	39.22	21.41	24.61	14.67	16.12	16.45
Net Cash (Debt)	391.41	492.62	480.85	284.52	202.34	298.98
Net Cash Growth	-0.65%	2.45%	69.01%	40.61%	-32.32%	8.04%
Net Cash Per Share	6.06	8.50	8.91	7.27	6.25	10.78

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-156.07	-109.08	-134.59	-75.79	-86.69	-69.13
Capital Expenditures	0.11	-0.54	-3.79	-2.77	-11.54	-9.11
Free Cash Flow	-155.97	-109.62	-138.37	-78.56	-98.22	-78.24
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	-109.22%	-125.91%	-	-	-	-240.17%
Operating Margin	-210.76%	-183.49%	-507678.38%	-544.65%	-3516.52%	-395.46%
Pretax Margin	-194.74%	-164.43%	-434778.38%	-486.59%	-3435.41%	-395.37%
Profit Margin	-194.74%	-164.43%	-434778.38%	-486.59%	-3435.41%	-395.37%
FCF Margin	-169.51%	-128.65%	-373975.68%	-379.11%	-3139.05%	-433.77%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	7.04	5.03	6959.14	41.80	229.93	39.09